Company Number: 14357880

Analysis Date: 2025-07-29 17:01 UTC

1. Credit Opinion: CONDITIONAL APPROVAL
   KLGOT LTD is a micro-entity in the human health activities sector, with modest asset and equity levels. The company shows minimal net assets (£116 as of 2024) and a slight reduction from the prior year (£530 in 2023). Current liabilities exceed current assets by a small margin, indicating a working capital deficiency, which poses some liquidity risk. However, the company remains active, with timely filings and no overdue accounts or returns. The single director and sole shareholder, Ms Kimberley Gazeley, has full control and appears committed. Credit approval can be cautiously considered if the loan amount and terms are aligned with the company's scale and cash flow realities, and provided ongoing monitoring is in place.

2. Financial Strength:
   The balance sheet reflects a very small scale with total net assets of only £116 and total current liabilities exceeding current assets by £1,364 in 2024, worsening from £1,690 in 2023. Fixed assets decreased slightly, and there is no significant capital buffer. The shareholder funds are minimal. The company’s financial base is fragile with limited equity cushion to absorb shocks or losses. This suggests limited financial strength and vulnerability to cash flow disruptions or unexpected expenses.

3. Cash Flow Assessment:
   Current liabilities exceed current assets, resulting in negative net current assets, which indicates potential stress in meeting short-term obligations. The average number of employees is one, implying low payroll burden. However, the negative working capital position limits the flexibility to manage liquidity needs effectively. No detailed cash flow statement was provided, but the balance sheet suggests tight cash flow conditions. The company must maintain careful cash management to avoid defaults.

4. Monitoring Points:

• Monitor current ratio and net current asset position closely for improvements or deterioration.
• Track profitability and cash flow generation in future accounts to ensure the ability to service debt.
• Watch for any late filings or changes in director status which might indicate operational or governance issues.
• Review any changes in shareholder equity and capital injections that could strengthen the financial base.
• Assess industry risks in the human health activities sector that could impact revenues and cash flows.